CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge
Front Immunol. 2018 Oct 23;9:2460. doi: 10.3389/fimmu.2018.02460.…
Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer
Mol Ther. 2019 Jan 2;27(1):230-243. doi: 10.1016/j.ymthe.2018.09.016.…
Enhanced Antitumor Efficacy of Oncolytic Adenovirus-loaded Menstrual Blood-derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells
Mol Cancer Ther. 2019 Jan;18(1):127-138. doi: 10.1158/1535-7163.MCT-18-0431.…
A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients
Hum Gene Ther. 2019 Mar;30(3):352-364. doi: 10.1089/hum.2018.107.…
Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma
Cancer Metastasis Rev. 2018 Sep;37(2-3):335-345. doi: 10.1007/s10555-018-9751-z.ABSTRACTUveal…
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice
Cancer Immunol Immunother. 2018 Oct;67(10):1589-1602. doi: 10.1007/s00262-018-2220-2.…
Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy
Cancer Res. 2018 Sep 1;78(17):4891-4901. doi: 10.1158/0008-5472.CAN-17-3754.…
Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus
Mol Ther Oncolytics. 2018 Jan 31;8:62-70. doi: 10.1016/j.omto.2018.01.003.…
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model
J Med Virol. 2018 Oct;90(10):1669-1673. doi: 10.1002/jmv.25229.…
A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
Clin Cancer Res. 2018 Aug 1;24(15):3717-3728. doi: 10.1158/1078-0432.CCR-17-3509.…
Promotion of malignant phenotype after disruption of the three-dimensional structure of cultured spheroids from colorectal cancer
Oncotarget. 2018 Mar 23;9(22):15968-15983. doi: 10.18632/oncotarget.24641.…
